Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven R Brenner

Showing results (11-20 of 33) with videos related to

Pageof 4
Sort By:
Neurology|January 26, 2006
Excess of serum copper not related to ceruloplasmin in Alzheimer diseaseSteven R Brenner
Neurology|January 13, 2010
Mitochondrial DNA haplogroups influence the therapeutic response to riboflavin in migraineursSteven R Brenner
Neurology|November 23, 2011
Neuronal intracellular transport and neurodegenerative diseaseSteven R Brenner
Neurology|June 16, 2005
A focus on the synapse for neuroprotection in Alzheimer disease and other dementiasSteven R Brenner
Neurology|July 23, 2014
Effects of Bacille Calmette-Guérin after the first demyelinating event in the CNSSteven R Brenner
Neurology|June 4, 2008
Re: Gray matter atrophy in Parkinson disease with dementia and dementia with Lewy bodiesSteven R Brenner
Journal of Medical Virology|May 22, 2020
The potential of memantine and related adamantanes such as amantadine, to reduce the neurotoxic effects of COVID-19, including ARDS and to reduce viral replication through lysosomal effectsSteven R Brenner
Neurology|July 7, 2025
Reader Response: Incidence and Prevalence of Early-Onset Dementia in FinlandSteven R Brenner
Neurology|July 4, 2012
Red blood cell omega-3 fatty acid levels and markers of accelerated brain agingSteven R Brenner
Neurology|February 16, 2006
Searching for a relationship between manganese and welding and Parkinson's diseaseSteven R Brenner
Pageof 4

Showing results (11-20 of 33) with videos related to

Sort By:
Pageof 4
Neurology|January 26, 2006
Excess of serum copper not related to ceruloplasmin in Alzheimer diseaseSteven R Brenner
Neurology|January 13, 2010
Mitochondrial DNA haplogroups influence the therapeutic response to riboflavin in migraineursSteven R Brenner
Neurology|November 23, 2011
Neuronal intracellular transport and neurodegenerative diseaseSteven R Brenner
Neurology|June 16, 2005
A focus on the synapse for neuroprotection in Alzheimer disease and other dementiasSteven R Brenner
Neurology|July 23, 2014
Effects of Bacille Calmette-Guérin after the first demyelinating event in the CNSSteven R Brenner
Neurology|June 4, 2008
Re: Gray matter atrophy in Parkinson disease with dementia and dementia with Lewy bodiesSteven R Brenner
Journal of Medical Virology|May 22, 2020
The potential of memantine and related adamantanes such as amantadine, to reduce the neurotoxic effects of COVID-19, including ARDS and to reduce viral replication through lysosomal effectsSteven R Brenner
Neurology|July 7, 2025
Reader Response: Incidence and Prevalence of Early-Onset Dementia in FinlandSteven R Brenner
Neurology|July 4, 2012
Red blood cell omega-3 fatty acid levels and markers of accelerated brain agingSteven R Brenner
Neurology|February 16, 2006
Searching for a relationship between manganese and welding and Parkinson's diseaseSteven R Brenner
Pageof 4